Devalingam Mahalingam
3 clinical trials · Sponsor
| Record | Firm | Date |
|---|---|---|
| Zanzalintinib in Second Line and Beyond for the Treatment of Advanced Liver Cancer (NCT07042919) | Devalingam Mahalingam | 2026-03-30 |
| Study of Sotorasib Combined With Chemotherapy for Second Line Treatment of Pancreas Cancer (NCT05251038) | Devalingam Mahalingam | 2022-09-13 |
Track Devalingam Mahalingam automatically
Every clearance here is in the API, with alerts when new ones post.